← FDA DRUG APPROVALS

FDA ANDA · ANDA084285

DICYCLOMINE HYDROCHLORIDE

Sponsor: LANNETT

APPLICATION
ANDA084285
TYPE
ANDA
ORIGINAL APPROVAL
1974-09-30
LATEST ACTION
2013-04-30
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

DICYCLOMINE HYDROCHLORIDEPrescription
DICYCLOMINE HYDROCHLORIDE 10MG · CAPSULE · ORAL

Approval history

2013-04-30Labeling · Supplement 15 · standardAP
2011-09-30Labeling · Supplement 14AP
2008-02-29Labeling · Supplement 12AP
2008-02-29Labeling · Supplement 13AP
2007-09-07Labeling · Supplement 11AP
2000-08-10Manufacturing (CMC) · Supplement 8AP
1998-08-07Manufacturing (CMC) · Supplement 7AP
1998-03-25Labeling · Supplement 6AP
1996-10-03Labeling · Supplement 4AP
1996-04-17Labeling · Supplement 3AP
1996-03-15Manufacturing (CMC) · Supplement 2AP
1974-09-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →